Japan
Modest gains seen in male infertility pharma
Modest gains seen in male infertility pharma
It is expected to register a 2.9% CAGR between 2025 and 2035.
Japan pressed to act as childhood myopia progresses faster
Experts warn slow adoption could double severe retinal disease by 2050.
Japan endoscopy market to grow 4% CAGR as robotic-assisted procedures expand
Rising gastrointestinal cancer cases are increasing demand for endoscopy procedures.
Japan leads Asia with 24 FDA novel-drug approvals: McKinsey
Regulatory fast-track supports global approvals, McKinsey says
Japan’s ultrasound systems market to reach $1.27b by 2034
The country represented 30% of the Asia-Pacific market in 2024.
Japan’s hip reconstruction market to be valued at $570m by 2036.
The country accounted for around 30% of the APAC market in 2024.
Japan delays medical expense reforms amidst political pushback
Overall health spending is still expected to surpass 12% of GDP by 2029.
Japan’s cardiac marker test market to reach $19m by 2036
The country accounted for 20% of the Asia-Pacific market in 2024.
Here’s what’s next for Japan’s mycobacterium tuberculosis tests market
The country accounted for about 4% of the Asia-Pacific market in 2024.
UCB JAPAN COMPANY LTD. receives ESG Program of the Year - Japan at Healthcare Asia Pharma Awards 2025
The company bagged the accolade for its effective environmental, social, and governance activities through external collaboration.
Kaikoukai Healthcare Group brings home win at Healthcare Asia Awards 2025
It has ensured seamless support for its foreign patients through its multilingual support system, advanced medical treatments and training programmes.
Shonan Kamakura General Hospital honoured at Healthcare Asia Awards 2025
It was awarded as the Hospital of the Year - Japan for its dedication to delivering the highest standards of medical care to patients around the world.
Japan’s 10-year fund to boost pharmaceutical landscape
The country’s ageing population is driving demand for innovative treatments.
Japan’s medical device market to be valued at $42.9b by 2029
It is projected to surpass Germany to become the third-largest market globally.
NCC, PREMIA, Paradigm unveil nationwide clinical trial network in Japan
The LC-SCRUM-CD serves as an expansion of the LC-SCRUM-Asia network.
Japan’s diabetes device market to hit $2.8b by 2032
Its growth is attributed to technological advancements and developments.
Japan’s healthcare market projects stability amidst new leadership
Shigeru Ishiba was elected as president of the ruling LDP, succeeding Fumio Kishida on 27 September.
Most Read
1. Diffusion to confusion: Solving APAC’s healthcare coordination crisis 2. Asia Pacific to lead surgical robots growth through 2034, Polaris says 3. Singapore develops world-first fluorescent nanosensor to track gut health 4. Kauvery Hospital brings advanced pulsed field ablation technologies to Chennai 5. Hong Kong doubles down on disease preventionResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Fragmented care has left patients facing inconsistent advice and complex journeys.
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential
Why health system research deserves more attention